Of course they were involved in the results. Or you think pfizer permitted use of their drugs without any interest in what happened? Pfizer had a front row seat and gave Kevetrin the big kiss off.
You mean this study. January 24, 2013 PR. Research by BIDMC combined Kevetrin with sunitinib (marketed as Sutent by Pfizer), on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that “the Kevetrin/sunitinib combination is the first we’ve used in which actual tumor shrinkage is noted.” Seems Lab test conducted alone by Beth Israel.